Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) Return on Equity (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Return on Equity for 16 consecutive years, with 0.38% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 93.0% to 0.38% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.38% through Dec 2025, up 93.0% year-over-year, with the annual reading at 0.4% for FY2025, 69.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.38% at Bristol Myers Squibb, down from 0.71% in the prior quarter.
  • The five-year high for Return on Equity was 2.46% in Q2 2023, with the low at 22.36% in Q2 2024.
  • Average Return on Equity over 5 years is 2.74%, with a median of 0.32% recorded in 2022.
  • The sharpest move saw Return on Equity skyrocketed 1636bps in 2023, then crashed -2481bps in 2024.
  • Over 5 years, Return on Equity stood at 2.95% in 2021, then tumbled by -448bps to 16.19% in 2022, then skyrocketed by 101bps to 0.18% in 2023, then crashed by -410bps to 0.55% in 2024, then surged by 169bps to 0.38% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.38%, 0.71%, and 8.03% for Q4 2025, Q3 2025, and Q2 2025 respectively.